The stock of Sera Prognostics Inc (SERA) has gone down by -27.65% for the week, with a -37.46% drop in the past month and a -54.99% drop in the past quarter. The volatility ratio for the week is 10.84%, and the volatility levels for the past 30 days are 7.97% for SERA. The simple moving average for the past 20 days is -30.67% for SERA’s stock, with a -65.48% simple moving average for the past 200 days.
Is It Worth Investing in Sera Prognostics Inc (NASDAQ: SERA) Right Now?
Moreover, the 36-month beta value for SERA is 0.99. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SERA is 23.41M and currently, short sellers hold a 3.36% of that float. On May 09, 2025, SERA’s average trading volume was 116.17K shares.
SERA) stock’s latest price update
Sera Prognostics Inc (NASDAQ: SERA) has experienced a decline in its stock price by -11.67 compared to its previous closing price of 2.40. However, the company has seen a fall of -27.65% in its stock price over the last five trading days. prnewswire.com reported 2025-05-08 that Industry Veteran to Spearhead Commercial Expansion, Driving Innovation and Growth at the Company SALT LAKE CITY, May 8, 2025 /PRNewswire/ — Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the appointment of Lee Anderson as Chief Commercial Officer. Bringing more than 30 years of cross-functional leadership experience in sales, marketing, customer service, strategic accounts, and training, Mr.
Analysts’ Opinion of SERA
Many brokerage firms have already submitted their reports for SERA stocks, with Citigroup repeating the rating for SERA by listing it as a “Neutral.” The predicted price for SERA in the upcoming period, according to Citigroup is $4 based on the research report published on March 30, 2022 of the previous year 2022.
Oppenheimer, on the other hand, stated in their research note that they expect to see SERA reach a price target of $19. The rating they have provided for SERA stocks is “Outperform” according to the report published on November 19th, 2021.
SERA Trading at -40.44% from the 50-Day Moving Average
After a stumble in the market that brought SERA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.28% of loss for the given period.
Volatility was left at 7.97%, however, over the last 30 days, the volatility rate increased by 10.84%, as shares sank -38.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -49.40% lower at present.
During the last 5 trading sessions, SERA fell by -27.65%, which changed the moving average for the period of 200-days by -72.18% in comparison to the 20-day moving average, which settled at $3.06. In addition, Sera Prognostics Inc saw -73.96% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SERA starting from Mirza Mansoor Raza, who proposed sale 107 shares at the price of $3.35 back on Apr 07 ’25. After this action, Mirza Mansoor Raza now owns shares of Sera Prognostics Inc, valued at $358 using the latest closing price.
Mirza Mansoor Raza, the Director of Sera Prognostics Inc, sale 107 shares at $3.35 during a trade that took place back on Apr 07 ’25, which means that Mirza Mansoor Raza is holding 43,778 shares at $358 based on the most recent closing price.
Stock Fundamentals for SERA
Current profitability levels for the company are sitting at:
- -475.78 for the present operating margin
- -0.06 for the gross margin
The net margin for Sera Prognostics Inc stands at -427.25. The total capital return value is set at -0.77. Equity return is now at value -55.78, with -39.12 for asset returns.
Based on Sera Prognostics Inc (SERA), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -16.89. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is -1308.39.
Currently, EBITDA for the company is -32.04 million with net debt to EBITDA at 0.1. When we switch over and look at the enterprise to sales, we see a ratio of 968.88. The receivables turnover for the company is 1.45for trailing twelve months and the total asset turnover is 0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.92.
Conclusion
To wrap up, the performance of Sera Prognostics Inc (SERA) has been bad in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
